FDA Gives Fast Track Designation to Sublingual Epinephrine for the Treatment of Severe Allergic Reactions

Kids With Food Allergies (KFA) is sharing this press release from Aquestive Therapeutics, Inc. to bring you the latest research news.[PRESS RELEASE] [Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-109 for Emergency Treatment of Allergic Reactions Including Anaphylaxis] WARREN, N.J. (GLOBE NEWSWIRE) – Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AQST-109, the first and only orally delivered epinephrine-based product candidate for …

Read the source article at Community
2022-03-24 17:42:53